Oritavancin

Status:

Red

Decision Date:

June 2022

Comments

RED: NICE ES39 – Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infections 

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating

search again